Seattle, July 12, 2018 (GLOBE NEWSWIRE) -- The global regulatory information management market is expected to witness considerable growth and exhibit a significant CAGR over the forecast period (2018–2026).
Request Sample Copy of this Report
Key Trends and Analysis of the Regulatory Information Management Market:
Regulatory information management software is expected to gain traction during the forecast period, owing to multiple factors such as changing regulatory scenario in industries such as biotechnology, pharmaceuticals, and clinical research, which is highly critical and needs to be updated at frequent intervals. This has led to development of competent regulatory information management software to be adopted by industry players. This ever-changing regulatory scenario in the market proves to be one of the important driving factors for adoption of regulatory information management software. Also, reduction in manual errors in the software designed for regulatory process coupled with easy access are further expected to contribute in growth of global regulatory information management market.
The market for regulatory information management is expected to experience significant traction during the forecast period, owing to increasing volume of data to be collected and provided by regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency, and other similar agencies in the respective regions globally to industry players.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/regulatory-information-management-market-1940
Key Market Takeaways:
- Some of the major players operating in the global regulatory information management market include Acuta, Llc, Parexel, Computer Sciences Corp (CSC), Aris Global, Virtify, Ennov, Amplexor, Samarind Ltd, Dovel Technologies, Inc., and Informa.
- The regulatory information management software demonstrates various features, which facilitates observance of updated regulations. With technologies for better surveillance of the regulations, to ensure effective management of regulatory information, the software also aid in reducing turnaround time for any issues or malpractices in the system. Pharmaceutical companies ensure substantial changes and updations in the regulations for respective pharmaceutical product and are involved in development, dissemination, and control of the regulatory information throughout the product development cycle. Regulatory information management is a solution for pharmaceutical companies in terms of efficient communication of regulations.